Advanced Biomed Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	0.13	-	-	-	-
Revenue Growth	-	-	-	-	-
Gross Profit	0.13	-	-	-	-
Selling, General & Admin	4.63	1.09	1.66	1.69	0.75
Research & Development	-	-	0.88	1.38	1.62
Operating Expenses	6.36	1.09	2.54	3.07	2.37
Operating Income	-6.23	-1.09	-2.54	-3.07	-2.37
Interest Expense	-0.01	-	-	-	-
Interest & Investment Income	-	-	0.05	0.02	0
Currency Exchange Gain (Loss)	-	-	-0.29	-0.51	-
Other Non Operating Income (Expenses)	-0.02	-	0	-0.02	-0.04
EBT Excluding Unusual Items	-6.26	-1.09	-2.78	-3.58	-2.41
Impairment of Goodwill	-	-	-	-	-1.62
Gain (Loss) on Sale of Assets	-	-	-	-0.15	-
Pretax Income	-6.26	-1.09	-2.78	-3.73	-4.03
Income Tax Expense	-0	-	-	-	-
Earnings From Continuing Operations	-6.26	-1.09	-2.78	-3.73	-4.03
Earnings From Discontinued Operations	12.94	-2.17	-	-	-
Net Income	6.68	-3.26	-2.78	-3.73	-4.03
Net Income to Common	6.68	-3.26	-2.78	-3.73	-4.03
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	1	1	1	1	1
Shares Outstanding (Diluted)	1	1	1	1	1
Shares Change	22.06%	2.63%	0.32%	40.55%	23.74%
EPS (Basic)	5.33	-3.18	-2.78	-3.74	-5.68
EPS (Diluted)	5.33	-3.18	-2.78	-3.74	-5.68
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Free Cash Flow	-1.95	-5.83	-2.2	-3.17	-1.63
Free Cash Flow Per Share	-1.55	-5.68	-2.20	-3.19	-2.30
Gross Margin	100.00%	-	-	-	-
Operating Margin	-4883.81%	-	-	-	-
Profit Margin	5231.30%	-	-	-	-
Free Cash Flow Margin	-1525.38%	-	-	-	-
EBITDA	-6.17	-0.74	-2.14	-2.84	-2.26
D&A For EBITDA	0.06	0.34	0.4	0.23	0.11
EBIT	-6.23	-1.09	-2.54	-3.07	-2.37

SEC Filings: 10-K · 10-Q